Jia En Wu

956 total citations
12 papers, 210 citations indexed

About

Jia En Wu is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Jia En Wu has authored 12 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Applied Microbiology and Biotechnology, 4 papers in Epidemiology and 4 papers in Clinical Biochemistry. Recurrent topics in Jia En Wu's work include Antibiotic Use and Resistance (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Urinary Tract Infections Management (2 papers). Jia En Wu is often cited by papers focused on Antibiotic Use and Resistance (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Urinary Tract Infections Management (2 papers). Jia En Wu collaborates with scholars based in Singapore, China and United States. Jia En Wu's co-authors include Li Yang Hsu, Douglas S. Chan, Jun Li, Li Liu, Feng Lü, Chao Tian, Lina Hu, Tat Ming Ng, Paul Anantharajah Tambyah and Hui Hiong Chen and has published in prestigious journals such as International Journal of Antimicrobial Agents, Antibiotics and Virulence.

In The Last Decade

Jia En Wu

11 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jia En Wu Singapore 6 97 69 47 43 42 12 210
M. Fellhauer Germany 6 63 0.6× 44 0.6× 4 0.1× 10 0.2× 36 0.9× 11 271
Ee Hui Goh Singapore 7 48 0.5× 35 0.5× 7 0.1× 5 0.1× 45 1.1× 8 154
Karine Bézulier France 4 87 0.9× 17 0.2× 6 0.1× 39 0.9× 88 2.1× 8 189
Krisy‐Ann Thornby United States 9 17 0.2× 36 0.5× 2 0.0× 6 0.1× 74 1.8× 26 253
O. O. Lyulko Germany 4 122 1.3× 37 0.5× 21 0.4× 37 0.9× 96 2.3× 4 317
Jon Hiles United States 7 52 0.5× 29 0.4× 9 0.2× 32 0.7× 85 2.0× 8 246
Rosaria Lionello Italy 8 34 0.4× 27 0.4× 13 0.3× 12 0.3× 55 1.3× 11 150
Valerie Cluzet United States 6 81 0.8× 14 0.2× 33 0.8× 54 1.3× 25 209
Firas Koura United States 4 25 0.3× 16 0.2× 18 0.4× 35 0.8× 86 2.0× 4 249
Mark Plautz United States 5 17 0.2× 47 0.7× 8 0.2× 5 0.1× 27 0.6× 7 195

Countries citing papers authored by Jia En Wu

Since Specialization
Citations

This map shows the geographic impact of Jia En Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia En Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia En Wu more than expected).

Fields of papers citing papers by Jia En Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia En Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia En Wu. The network helps show where Jia En Wu may publish in the future.

Co-authorship network of co-authors of Jia En Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jia En Wu. A scholar is included among the top collaborators of Jia En Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia En Wu. Jia En Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ng, Tat Ming, Li Wei Ang, Andrea Lay‐Hoon Kwa, et al.. (2023). Antibiotic utilisation and resistance over the first decade of nationally funded antimicrobial stewardship programmes in Singapore acute-care hospitals. Antimicrobial Resistance and Infection Control. 12(1). 82–82. 3 indexed citations
2.
Niu, Yue, et al.. (2023). Circ_0001715 accelerated lung adenocarcinoma process by the miR-1322/CANT1 axis. Diagnostic Pathology. 18(1). 91–91. 3 indexed citations
3.
Chen, Hui Hiong, et al.. (2021). Antibiotic stewardship algorithm to rationalise antibiotic use amonghospitalised COVID-19 patients. Annals of the Academy of Medicine Singapore. 50(4). 366–368.
4.
Wu, Jia En, et al.. (2020). The Case for Intermittent Carbapenem Dosing in Stable Haemodialysis Patients. Antibiotics. 9(11). 815–815. 1 indexed citations
5.
Chen, Hui Hiong, Douglas Chan, Siew‐Pang Chan, et al.. (2020). A Prediction Tool for the Presence of Ceftriaxone-Resistant Uropathogens upon Hospital Admission. Antibiotics. 9(6). 316–316. 4 indexed citations
6.
Tan, Sock Hoon, Tat Ming Ng, Ka Lip Chew, et al.. (2019). Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems. International Journal of Antimicrobial Agents. 55(2). 105860–105860. 28 indexed citations
7.
Wu, Jia En, et al.. (2018). An evaluation of the intravenous to oral antimicrobial conversion program in the inpatient setting. Journal of Pharmacy Practice and Research. 48(3). 269–276. 1 indexed citations
8.
Wu, Yi‐Ying, et al.. (2016). CASZ1 is a novel promoter of metastasis in ovarian cancer.. PubMed. 6(6). 1253–70. 9 indexed citations
9.
Li, Jun, Lina Hu, Chao Tian, et al.. (2015). microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4. BMC Molecular Biology. 16(1). 24–24. 62 indexed citations
10.
Wu, Jia En, et al.. (2013). Antimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospital. Antimicrobial Resistance and Infection Control. 2(1). 29–29. 13 indexed citations
11.
Wu, Jia En, et al.. (2013). Antimicrobial stewardship. Virulence. 4(2). 151–157. 73 indexed citations
12.
Wu, Jia En, et al.. (2012). Specialist trainees on rotation cannot replace dedicated consultant clinicians for antimicrobial stewardship of specialty disciplines. Antimicrobial Resistance and Infection Control. 1(1). 36–36. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026